Henstedt-Ulzburg, Germany

Vera Planitz

This inventor holds 1 USPTO granted patent. Top assignee: Beiersdorf Ag. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vera Planitz: Innovator in Pharmaceutical Composition

Introduction

Vera Planitz is a notable inventor based in Henstedt-Ulzburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that combine various active ingredients.

Latest Patents

Vera Planitz holds a patent for a pharmaceutical composition that includes moxonidine and hydrochlorothiazide. This composition is designed to provide therapeutic benefits through the combination of these two compounds, which are known for their effectiveness in treating specific medical conditions. The patent details the formulation of moxonidine, a compound with the chemical structure 4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine, along with hydrochlorothiazide, which is identified as 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide. Additionally, the formulation may include triamterene, a compound known for its diuretic properties.

Career Highlights

Vera Planitz is currently associated with Beiersdorf AG, a leading company in the consumer goods sector, particularly known for its skincare products. Her work at Beiersdorf AG has allowed her to focus on pharmaceutical innovations that enhance patient care and treatment options.

Collaborations

Throughout her career, Vera has collaborated with esteemed colleagues, including Ben Armah and Wolfgang Stenzel. These partnerships have contributed to her success in developing effective pharmaceutical solutions.

Conclusion

Vera Planitz exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patent for a unique pharmaceutical composition, highlight her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…